The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II clinical trial of talazoparib monotherapy for PALB2 mutation-associated advanced breast cancer.
 
Joshua James Gruber
Employment - BD Biosciences (I); Guardant Health (I)
Stock and Other Ownership Interests - BD Biosciences (I); Guardant Health (I)
Consulting or Advisory Role - Hummingbird
Research Funding - Curis; Pfizer
Patents, Royalties, Other Intellectual Property - Stanford University
 
Wyatt Gross
Research Funding - Pfizer
 
Alex McMillan
Research Funding - Pfizer
 
James M. Ford
Research Funding - AstraZeneca (Inst); Genentech (Inst); Pfizer (Inst); Puma Biotechnology (Inst)
 
Melinda L. Telli
Consulting or Advisory Role - Abbvie; Aduro Biotech; Celgene; Daiichi Sankyo; G1 Therapeutics; Genentech/Roche; Immunomedics; Lilly; Merck; Natera; Pfizer
Research Funding - Abbvie (Inst); Bayer (Inst); Biothera (Inst); Calithera Biosciences (Inst); EMD Serono (Inst); Genentech (Inst); Medivation (Inst); Novartis (Inst); OncoSec (Inst); Pfizer (Inst); PharmaMar (Inst); Tesaro (Inst); Vertex (Inst)
Other Relationship - G1 Therapeutics; Pfizer (I)